Raivo Unt
CEO
Raivo Unt serves as the CEO at Noya Therapeutics, bringing extensive experience in financial management and strategic development within the pharmaceutical industry.
His expertise in financial strategy and operational efficiency led him to the position of Financial Director at AO “Starman”, a subsidiary of the Swedish company “Telia – Sonera”, where he was instrumental in securing funding for continuous company operations and developing comprehensive business plans.
Mr Unt expanded his influence in the pharmaceutical sector as a shareholder of PharmSynthez and played a key role in the acquisition of companies and investor engagement. His leadership was further demonstrated as Chairman of the Board at KEVELT, a subsidiary of PharmSynthez, where he oversaw significant company developments and effective team coordination.
Beyond his corporate achievements, Mr Unt’s contributions to the pharmaceutical industry are notable for his participation in constructing and launching new pharmaceutical manufacturing facilities, showcasing his comprehensive knowledge and hands-on experience in the field.
